Therapeutics targeting CD90-integrin-AMPK-CD133 signal axis in liver cancer

CD90 is used as a marker for cancer stem cell in liver cancer. We aimed to study the mechanism by which CD90 promoted liver cancer progression and identify the new therapeutic targets on CD90 signal pathway. Ectopic expression of CD90 in liver cancer cell lines enhanced anchorage-independent growth...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Wei-Ching, Chang, Yung-Sheng, Hsu, Hui-Ping, Yen, Meng-Chi, Huang, Hau-Lun, Cho, Chien-Yu, Wang, Chih-Yang, Weng, Tzu-Yang, Lai, Po-Ting, Chen, Ching-Shih, Lin, Yih-Jyh, Lai, Ming-Derg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4767481/
https://www.ncbi.nlm.nih.gov/pubmed/26556861

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4767481/
https://www.ncbi.nlm.nih.gov/pubmed/26556861

Ejemplares similares